I am an empirical researcher interested in healthcare marketing, innovation, biopharma, healthcare consumption, drug competition, and public health.
I teach marketing analytics and marketing research.
WORKING PAPERS
"Does Brand Equity Affect Perceived Drug Safety?"
with A. Ching and H. Tyagi.
Under review (2026).
"Patient Assistance or Commercial Targeting? Characterizing the Income Gradient in Drug Coupon Utilization"
with M. A. Sanchez, A. J. Trujillo, J. Gibbons, and S.-Y. Kang.
2026.
"Cutting out the Middleman: Has Mark Cuban Cost Plus Drugs Reduced Prices of Prescription Drugs?"
with A. Janssen and J. Li.
Under review (2026).
"Does Gender Matter for Responsible Development? Evidence from Clinical Trials"
Under second-round review, Research Policy (February 2026).
"Biosimilar Turf Wars"
with K. Anderson and J. Levy.
Revise and resubmit, Review of Economics and Statistics (October 2025).
"Resistance Shocks and Last-Resort Antibiotic Use in Urban India"
with S. Agrawal, C. Chatterjee, and E. Klein.
Under review (2026).
"Manufacturer Coupon Offsets and Payer Spending Over Time During GLP-1 Treatment Among Commercially Insured Patients"
with M. Kim and S.-Y. Kang.
Under review (2026).
PEER REVIEWED PUBLICATIONS
"Motivational Themes in Digital Advertisements Enhance Recruitment Efficiency in Cardiovascular Trials"
with J. Cao, J. Cha, T. Harry, T. B. Plante, H. Col, D. Patil, R.-A. N. Turkson-Ocran, Y. Feng, M. Zhang, and S. P. Juraschek.
Contemporary Clinical Trials 169 (2026): 108413.
"Buyer Power in Advertising: Healthy Food Pays More for Visibility"
with N. Guzman-Tordecilla, A. Trujillo, and A. Vecino-Ortiz.
Journal of Public Policy & Marketing, published online July 7, 2026.
"Manufacturer-Sponsored Coupon Use and Brand-Name Drug Costs Among Patients With Insurance"
with S.-Y. Kang, M. Kim, and J. F. Levy.
JAMA 335(20) (2026): 1812–1814.
"Representation and Career Trajectories of Female Principal Investigators in Clinical Trials, 2010–2023"
Contemporary Clinical Trials Communications 48 (2025): 101566.
"Does Transparency Hinder Technological Novelty? Evidence from Large Pharmaceutical Firms"
with H. Tyagi and R. Shah.
Manufacturing & Service Operations Management 27(5) (2025): 1415–1432.
"On the Motivation for Pharmaceutical Manufacturer Coupons: Brand Loyalty or Customer Acquisition?"
with J. Gibbons and A. Trujillo.
Health Services Research 60(2) (2025): e14379.
"Regulating Ethical Experimentation: Impacts of the Breakthrough Therapy Designation on Drug R&D"
Journal of Health Economics 94 (2024): 102855.
"Does Bad Medical News Reduce Preferences for Generic Drugs?"
with A. Ching.
Journal of Marketing 88(1) (2024): 160–178.
"Leveraging the E-commerce Footprint for the Surveillance of Healthcare Utilization"
with J. Ni, H. Wang, and J. Zhang.
Health Care Management Science 26(4) (2023): 604–625.
"Association Between Universal Health Coverage and the Disease Burden of Acute Illness and Injury at the Global Level"
with K. Hajjar, L. Lillo, D. A. Martinez, and N. Risko.
BMC Public Health 23 (2023): 735.
"COVID-19 Unemployment and Access to Statin Medications in the United States"
with C. Alexander and D. Polsky.
Frontiers in Public Health 11 (2023): 1124151.
"Does Consumer Demand Pull Scientifically Novel Drug Innovation?"
with D. Dranove and C. Garthwaite.
The RAND Journal of Economics 53(3) (2022): 590–638.
"Prospective Adverse Event Risk Evaluation in Clinical Trials"
with A. Kundu, F. Feijoo, D. A. Martinez, and T. Matis.
Health Care Management Science 25(1) (2022): 89–99 (lead article).
"Rushed Innovation: Evidence from Drug Licensing"
Management Science 67(1) (2021): 257–278.
"Can Emerging Markets Tilt Global Product Design? Impacts of Chinese Colorism on Hollywood Castings"
with F. Gutiérrez-Navratil and J. Prieto-Rodríguez.
Marketing Science 37(3) (2018): 356–381.
"Market Size and Innovation: The Intermediary Role of Technology Licensing"
with Y. Wu.
Research Policy 47(5) (2018): 980–991.
"Use of Online Recruitment Strategies in a Randomized Trial of Cancer Survivors"
with S. P. Juraschek, T. B. Plante, J. Charleston, E. R. Miller, H.-C. Yeh, L. J. Appel, G. J. Jerome, D. Gayles, N. Durkin, K. White, and A. Dalcin.
Clinical Trials 15(2) (2018): 130–138.
OTHER PUBLICATIONS
"Structural Models of the Prescription Drug Market"
with A. Ching and Q. Liu.
Foundations and Trends in Marketing 13(1) (2019): 1–76.
"Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS"
with J. Lemus.
In Economic Dimensions of Personalized and Precision Medicine, E. R. Berndt, D. P. Goldman, and J. W. Rowe, eds., University of Chicago Press, 2019, pp. 21–52.
"Renegociación de Concesiones en Chile"
with E. Engel, A. Galetovic, and R. Fischer.
Estudios Públicos 113 (2009): 151–205.
"La Renegociación de Concesiones y la Nueva Ley"
with E. Engel, A. Galetovic, and R. Fischer.
Puntos de Referencia 297 (September 2008).